Related Experiment Video
Updated: Jun 20, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
Published on: March 27, 2026
Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma
M Kashif Ishaqi1, A Jamil, M Khanani
1Division of Pediatric Hematology/Oncology, Tawam Hospital, Johns Hopkins Medicine, Al-Ain, United Arab Emirates. kishaqi@hotmail.com
Abstract:
Hepatic Sinusoidal Obstruction Syndrome (HSOS), the new name given to veno-occlusive disease (VOD) of the liver, is a well-known complication of high-dose chemotherapy employed with hematopoietic stem cell transplantation, but it has rarely been observed in children who receive conventional chemotherapy. HSOS following standard chemotherapy has been reported in patients receiving vincristine, actinomycin D, and cyclophosphamide for the treatment of Wilms tumor and more rarely rhabdomyosarcoma. We report a 14-year-old boy with high risk medulloblastoma treated with craniospinal radiation followed by chemotherapy, who experienced severe HSOS after only one course of chemotherapy including carboplatin, vincristine, and cyclophosphamide. To our knowledge, this is the second report of HSOS after standard dose chemotherapy for brain tumor in childhood.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pyloric Obstruction
Pharmacokinetics in Pediatric Patients: Drug Distribution
